{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:13:09Z","timestamp":1761822789690},"reference-count":38,"publisher":"Elsevier BV","issue":"34","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.vaccine.2005.03.031","type":"journal-article","created":{"date-parts":[[2005,4,28]],"date-time":"2005-04-28T13:14:07Z","timestamp":1114694047000},"page":"4307-4314","source":"Crossref","is-referenced-by-count":19,"title":["Immunogenicity of an investigational quadrivalent Neisseria meningitidis-diphtheria toxoid conjugate vaccine in 2-year old children"],"prefix":"10.1016","volume":"23","author":[{"given":"Dan M.","family":"Granoff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo Anne","family":"Welsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.vaccine.2005.03.031_bib1","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1097\/00006454-200210000-00019","article-title":"Dose escalation, safety and immunogenicity study of a tetravalent meninogococcal polysaccharide diphtheria conjugate vaccine in toddlers","volume":"21","author":"Rennels","year":"2002","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.vaccine.2005.03.031_bib2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/01.inf.0000148928.10057.86","article-title":"Comparative trial of the safety and immunogenicity of quadrivalent (A, C, Y, W-135) meningococcal polysaccharide-diphtheria conjugate vaccine versus quadrivalent polysaccharide vaccine in two- to ten-year-old children","volume":"24","author":"Pichichero","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"10.1016\/j.vaccine.2005.03.031_bib3","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1086\/345763","article-title":"Safety, reactogenicity, and immunogenicity of a tetravalent meningococcal polysaccharide-diphtheria toxoid conjugate vaccine given to healthy adults","volume":"186","author":"Campbell","year":"2002","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2005.03.031_bib4","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/01.inf.0000154438.37306.ab","article-title":"The future of meningococcal vaccines","volume":"24","author":"Healy","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.vaccine.2005.03.031_bib5","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/01.inf.0000129686.12470.e6","article-title":"Protective activity of group C anticapsular antibodies elicited in two-year-olds by an investigational quadrivalent Neisseria meningitidis-diphtheria toxoid conjugate vaccine","volume":"23","author":"Granoff","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.vaccine.2005.03.031_bib6","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.inf.0000151035.64356.f8","article-title":"Persistence of group C anticapsular antibodies two to three years after immunization with an investigational quadrivalent Neisseria meningitidis-diphtheria toxoid conjugate vaccine","volume":"24","author":"Granoff","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"10.1016\/j.vaccine.2005.03.031_bib7","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.vaccine.2004.07.042","article-title":"Naturally-acquired immunity to Neisseria meningitidis group A","volume":"23","author":"Amir","year":"2005","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2005.03.031_bib8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1128\/IAI.71.1.275-286.2003","article-title":"Age-related disparity in functional activities of human group C serum anticapsular antibodies elicited by meningococcal polysaccharide vaccine","volume":"71","author":"Harris","year":"2003","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2005.03.031_bib9","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/01.inf.0000135659.52662.a2","article-title":"Serum group A anticapsular antibodies in a Sudanese population immunized with meningococcal polysaccharide vaccine during a group A epidemic","volume":"23","author":"Ismail","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.vaccine.2005.03.031_bib10","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","article-title":"Human immunity to the meningococcus. I. The role of humoral antibodies","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.vaccine.2005.03.031_bib11","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1128\/CDLI.10.5.780-786.2003","article-title":"Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England","volume":"10","author":"Andrews","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2005.03.031_bib12","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1128\/IAI.69.3.1568-1573.2001","article-title":"Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection","volume":"69","author":"Borrow","year":"2001","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2005.03.031_bib13","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.vaccine.2003.08.040","article-title":"Scientific challenges for the quality control and production of group C meningococcal conjugate vaccines","volume":"22","author":"Jodar","year":"2004","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2005.03.031_bib14","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1128\/IAI.40.1.257-264.1983","article-title":"Importance of complement source in bactericidal activity of human antibody and murine monoclonal antibody to meningococcal group B polysaccharide","volume":"40","author":"Zollinger","year":"1983","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2005.03.031_bib15","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1128\/CDLI.8.3.616-623.2001","article-title":"Importance of complement source in measuring meningococcal bactericidal titers","volume":"8","author":"Santos","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2005.03.031_bib16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1542\/peds.76.1.91","article-title":"Evaluation of two tetravalent (ACYW135) meningococcal vaccines in infants and small children: a clinical study comparing immunogenicity of O-acetyl-negative and O-acetyl-positive group C polysaccharides","volume":"76","author":"Peltola","year":"1985","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2005.03.031_bib17","series-title":"Vaccines","article-title":"Meningococcal Vaccines","author":"Granoff","year":"2003"},{"issue":"31","key":"10.1016\/j.vaccine.2005.03.031_bib18","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1016\/S0264-410X(01)00209-2","article-title":"Surveillance for meningococcal disease and strategies for use of conjugate meningococcal vaccines in the United States","volume":"19","author":"Lingappa","year":"2001","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2005.03.031_bib19","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1086\/315158","article-title":"The changing epidemiology of meningococcal disease in the United States","volume":"180","author":"Rosenstein","year":"1999","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2005.03.031_bib20","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1084\/jem.162.6.1837","article-title":"Escherichia coli K51 and K93 capsular polysaccharides are crossreactive with the group A capsular polysaccharide of Neisseria meningitidis. Immunochemical, biological, and epidemiological studies","volume":"162","author":"Guirguis","year":"1985","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.vaccine.2005.03.031_bib21","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/infdis\/135.1.94","article-title":"Cross-antigenicity and immunogenicity between capsular polysaccharides of group C Neisseria meningitidis and of Escherichia coli K92","volume":"135","author":"Glode","year":"1977","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2005.03.031_bib22","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1084\/jem.129.6.1327","article-title":"Human immunity to the meningococcus. II. Development of natural immunity","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"issue":"7","key":"10.1016\/j.vaccine.2005.03.031_bib23","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1128\/IAI.70.7.3621-3626.2002","article-title":"Neisseria lactamica protects against experimental meningococcal infection","volume":"70","author":"Oliver","year":"2002","journal-title":"Infect Immun"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2005.03.031_bib24","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0264-410X(00)00333-9","article-title":"Development of natural immunity to Neisseria meningitidis","volume":"19","author":"Pollard","year":"2001","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2005.03.031_bib25","doi-asserted-by":"crossref","first-page":"5903","DOI":"10.1128\/IAI.72.10.5903-5909.2004","article-title":"Naturally acquired passive protective activity against Neisseria meningitidis Group C in the absence of serum bactericidal activity","volume":"72","author":"Welsch","year":"2004","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2005.03.031_bib26","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1086\/317646","article-title":"Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers","volume":"183","author":"Richmond","year":"2001","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2005.03.031_bib27","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1017\/S0950268899003787","article-title":"Induction of immunological memory in UK infants by a meningococcal A\/C conjugate vaccine","volume":"124","author":"Borrow","year":"2000","journal-title":"Epidemiol Infect"},{"issue":"6","key":"10.1016\/j.vaccine.2005.03.031_bib28","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1086\/314753","article-title":"Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory","volume":"179","author":"Richmond","year":"1999","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2005.03.031_bib29","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1086\/344324","article-title":"Antibody persistence and immunological memory at age 4 years after meningococcal group C conjugate vaccination in children in the United kingdom","volume":"186","author":"Borrow","year":"2002","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2005.03.031_bib30","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/infdis\/175.1.200","article-title":"Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide\u2013protein conjugate vaccine","volume":"175","author":"Leach","year":"1997","journal-title":"J Infect Dis"},{"issue":"19","key":"10.1016\/j.vaccine.2005.03.031_bib31","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1001\/jama.280.19.1685","article-title":"Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial","volume":"280","author":"MacDonald","year":"1998","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.vaccine.2005.03.031_bib32","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00006454-200103000-00002","article-title":"Imperfect memory and the development of Haemophilus influenzae type B disease","volume":"20","author":"Lucas","year":"2001","journal-title":"Pediatr Infect Dis J"},{"issue":"4 Pt 1","key":"10.1016\/j.vaccine.2005.03.031_bib33","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1542\/peds.101.4.604","article-title":"Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants","volume":"101","author":"Rennels","year":"1998","journal-title":"Pediatrics"},{"issue":"5 Pt 1","key":"10.1016\/j.vaccine.2005.03.031_bib34","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0022-3476(96)80130-2","article-title":"Immunogenicity of heptavalent pneumococcal conjugate vaccine in infants","volume":"128","author":"Anderson","year":"1996","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.vaccine.2005.03.031_bib35","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1086\/322790","article-title":"Meningococcal serogroup a avidity indices as a surrogate marker of priming for the induction of immunologic memory after vaccination with a meningococcal A\/C conjugate vaccine in infants in the United Kingdom","volume":"184","author":"Joseph","year":"2001","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2005.03.031_bib36","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1086\/517407","article-title":"Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization","volume":"177","author":"Goldblatt","year":"1998","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2005.03.031_bib37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1473-3099(04)01251-4","article-title":"Meningococcal polysaccharide-protein conjugate vaccines","volume":"5","author":"Snape","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2005.03.031_bib38","unstructured":"Food and drug administration vaccines and related biological products advisory committee. Rockville Maryland; 2004 [license application for the tetravalent meningococcal conjugate vaccine, Menactra, manufactured by Aventis Pasteur, Inc.]."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05004263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05004263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T02:53:43Z","timestamp":1683082423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X05004263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":38,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S0264410X05004263"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2005.03.031","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}